Onconic Therapeutics Inc.
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
476060 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로26길 12 제일비젼타워 11층, 강남구
- Website:
- http://onconic.co.kr/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Onconic Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative drugs for cancer and gastrointestinal diseases. A subsidiary of Jeil Pharmaceutical, the company focuses on therapeutic areas with high unmet medical needs and significant market potential. Its development pipeline features novel treatments for acid-related conditions, including ZacuCorrection (zastaprazan), a next-generation potassium-competitive acid blocker (P-CAB) designed to treat gastroesophageal reflux disease. Onconic Therapeutics aims to advance its portfolio through clinical development and strategic collaborations to bring new therapeutic options to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
Share Issue/Capital Change
주권매매거래정지 (무상증자)
|
Korean | 4.8 KB | ||
| 2025-09-17 00:00 |
Share Issue/Capital Change
주요사항보고서(무상증자결정)
|
Korean | 10.2 KB | ||
| 2025-09-15 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획변경승인) (자큐보정(JP1366)(자스타프라잔시트르산염)의 약물상호작용 확인을 위한…
|
Korean | 11.6 KB | ||
| 2025-09-05 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-09-01 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-22 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-19 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (파트너사인 Livzon Pharmaceutical Group Inc.에 Zastaprazan(…
|
Korean | 10.4 KB | ||
| 2025-08-18 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획변경승인신청) (네수파립의 췌장암 제1b/2상 임상시험계획승인(변경승인)신청))
|
Korean | 10.7 KB | ||
| 2025-08-11 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 929.6 KB | ||
| 2025-08-01 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인신청) (자큐보정 JP-1366 약물상호작용 확인을 위한 1상 임상시험계획승인…
|
Korean | 10.7 KB | ||
| 2025-07-30 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획변경승인신청) (네수파립의 위암 제1b/w상 임상시험계획승인(변경승인)신청)
|
Korean | 11.5 KB | ||
| 2025-07-30 00:00 |
Regulatory News Service
[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (네수파립의 위암 제1b/2상 임상시험계획승인(변경승인)신청)
|
Korean | 14.7 KB | ||
| 2025-07-02 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획변경승인) (자큐보정(JP-1366)(자스타프라잔시트르산염)의 비미란성 위식도역류질환…
|
Korean | 11.3 KB | ||
| 2025-06-17 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (국산신약 37호 자큐보정의 품목허가사항 변경허가 승인(위궤양 신규적응증 추가를 위한 한국 식품…
|
Korean | 7.7 KB | ||
| 2025-05-26 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB |
Automate Your Workflow. Get a real-time feed of all Onconic Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Onconic Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
